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Relación entre la hipertrabeculación
ventricular izquierda y el ejercicio. 
Introducción: Miocardiopatía no compactada. Definición.
• La miocardiopatía no
compactada (MNC) es una
anormalidad estructural del
miocardio de etiología y
mecanismo inciertos
(componente genético).
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of DCM has been difficult to standardize given the influence 
of body size, athletic training, and biological heterogeneity on 
measurements of left ventricular volume and contractile func-
tion. Prevalence data also vary when disease expression is re-
lated to age (HCM),23,24 age and sex (Brugada syndrome),25–27 
or is present at birth (LQT).28,29 In addition, founder effects 
may influence prevalence and perceptions of disease severity 
(ARVC).30,31
Table 1 presents a summary of disease prevalence in chil-
dren and adults for HCM, DCM, ARVC, RCM, and chan-
nelopathies. A disease prevalence of 1:250 to 500 for HCM 
in adults seems to be similar in all races, and disease expres-
sion usually occurs in adolescents and young adults, whereas 
Figure 7. Restrictive cardiomyopathy. 
A, Cardiac specimen sectioned to 
reveal a 4-chamber view: the small 
nonhypertrophied ventricles look like 
appendages of the very dilated atria. Note 
the absence of pericardial, endocardial, 
or valvular disease. B, The restriction 
is primarily of the myocardium, which 
reveals myocyte disarray. Azan stain.
Figure 8. Endocardial fibroelastosis. A, Cross section of 
the ventricles: note the whitish, thickened, pearly colored 
endocardium. B, At histology, the endocardial thickness consists 
of elastic fibers. Weigert stain.
Figure 9. Left ventricular noncompaction. A, Specimen cut 
to reveal 4-chamber view with coarse trabeculations in the left 
ventricular cavity and deep intertrabecular spaces. B, Histology: 
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Porción endocárdica (no compactada) de
aspecto espongiforme (trabéculas
prominentes y recesos intertrabeculares)
que se comunican con la cavidad de VI y
están rellenos de sangre.
Porción epicárdica (compactada)
Towbin. Circ Res 2017• Afectación predominante: VI.
• Se caracteriza por el siguiente
patrón:
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• Clasificación: Miocardiopatía primaria (genética) por la AHA
(2006) y miocardiopatía no clasificada por la ESC (2008).
Maron. Circulation 2006.
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it is uncommon in children.23,24 Robust data on the epidemi-
ology of DCM are lacking, but estimates suggest incidence 
and prevalence figures of approximately twice those seen in 
HCM.32 Incidence in children is greatest in the first year of 
life (4.58/100 000) and much less common from age 1 to 18 
years (0.34/100 000).20 The prevalence of ARVC has not been 
systematically studied, but is estimated at 1/2000 to 500033,34; 
robust epidemiological data are lacking in part because of the 
multiple clinical evaluations required for diagnosis. ARVC in 
childhood is rare, and, like in HCM, disease expression usu-
ally occurs during adolescence and early adulthood, but may 
develop at any age, in keeping with the concept of genetically 
determined cardiomyopathy.34
For LQT syndrome, a prevalence of 1:2000 has been 
established in neonates, and data suggest that this is similar 
for all ages and races, although event rates differ for LQT1, 
LQT2, and LQT3 with respect to age and sex.28,29,35
Criteria for the diagnosis of Brugada syndrome include a 
type 1 ECG pattern (coved ST-segment elevation with J point 
amplitude ≥0.2 mV followed by negative T wave) with at least 
1 additional feature suggestive of arrhythmia (eg, unexplained 
sudden cardiac death aged <45 years in a relative).25,36
Figure 10. American Heart Association Classification of Cardiomyopathies. Primary cardiomyopathies in which the clinically relevant 
disease processes solely or predominantly involve the myocardium. The conditions have been segregated according to their genetic or 
nongenetic causes. *Predominantly nongenetic; familial disease with a genetic origin has been reported in a minority of cases. ARVC/D 
indicates arrhythmogenic right ventricular cardiomyopathy/dysplasia; CPVT, catecholaminergic polymorphic ventricular tachycardia; 
DCM, dilated cardiomyopathy; HCM, hypertrophic cardiomyopathy; LQTS, long-QT syndrome; LVNC, left ventricular noncompaction; 
SQTS, short-QT syndrome; and SUNDS, sudden unexpected nocturnal death syndrome. Reproduced from Maron et al17 with permission 
of the publisher. Copyright ©2006, American Heart Association, Inc.
Figure 11. European Society 
of Cardiology Classification of 
Cardiomyopathies. Summary of 
proposed classification system. 
ARVC indicates arrhythmogenic right 
ventricular cardiomyopathy; DCM, dilated 
cardiomyopathy; HCM, hypertrophic 
cardiomyopathy; and RCM, restrictive 
cardiomyopathy. From Elliott et al18 with 
permission of the publisher. Copyright 
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Elliot. EHJ 2008. 
Introducción: Miocardiopatía no c pactada. Clasificación. 
Introducción: Miocardiopatía no compactada. 
Etiopatogenia. 
detected by retrospective clonal analysis, are present 
before activation of Mesp1 or Smarcd3, thus before 
gastrulation22,26,29.
Live imaging of early heart formation. Live- imaging 
experiments of mouse embryos at the time of heart 
tube formation have provided insight into the dynam-
ics of myocardial differentiation19. Myocardial differ-
entiation was shown to occur in two phases. The first 
wave occurs at the early head- fold stage during 5–6 h 
and corresponds to the formation of the cardiac cres-
cent. A pause of 5–7 h is observed before myocardial 
differentiation is re- initiated when the heart tube starts 
looping, providing cells for the elongation of the heart 
tube. These waves of differentiation are consistent with 
the two myocardial lineages ingressing sequentially 
through the primitive streak and thus reaching the heart 
region sequentially.
Myocardial sublineages. Further information about 
myocardial sublineages (FIG. 2) came from analysis of 
clonal contributions to the anterior skeletal muscles 
of the head and neck, which also express Actc1 during 
development. These anterior muscles, which derive from 
mesoderm present in the pharyngeal arches31 (BOX 1), are 
clearly detectable by E14.5. Retrospective clonal analy-
sis at E14.5 showed that masticatory muscles, derived 
from the mesoderm of the first pharyngeal arch, share 
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Fig. 1 | Cardiogenesis stages in the mouse. After gastrulation, cardiac progenitors migrate laterally towards the 
head folds at embryonic day (E) 7.25 (arrow), where the cardiac crescent forms (E7.5). At E8.5, the heart tube, which is 
composed of an inner layer of endocardium (yellow) and an outer layer of myocardium (orange), elongates from both 
the arterial (Ap) and venous (Vp) poles (arrows). At E10.5, cardiac chambers are visible as bulges from the heart tube. 
The proepicardium (E8.5) gives rise to the epicardium, which covers the myocardial surface and gives rise to interstitial 
fibroblasts (arrows), shown in the ventricular wall (E13.5). Coronary veins form superficially compared with coronary 
arteries. The different compartments and tissues of the heart are shown at E16.5. Ao, aorta; ICV, inferior caval vein; 
IVS, interventricular septum; L A , left atrium; LV, left ventricle; OFT, outflow tract; PA , pulmonary artery ; PV, pulmonary 
vein; RA , right atrium; RV, right ventricle; SCV, superior caval vein. Adapted with permission from REF.192, Cold Spring 
Harbor Laboratory Press.
Meilhac. Nat reviews 2018.
• Se han identificado varias mutaciones (genes sarcoméricos,
citoesqueleto y membrana nuclear) relacionadas con la enfermedad
y existe una asociación familiar.
• ↓ prevalencia global: 0,01-0,3% de los adultos referidos para
ecocardiograma; hasta 3-4% en pacientes con diagnóstico de IC.
• Varias formas clínicas:




- MNC biventricular o con afectación de VD.
- MNC asociada a otras C. congénitas.
• ↑ riesgo tromboembolismo.
Introducción: Miocardiopatía no compactada. 
Características.
Towbin. Lancet 2015.
• Diagnóstico: Técnicas de imagen.
• Problema: Solapamiento fenotípico con otras entidades (MCH, MCD,
algunas condiciones fisiológicas).
Introducción: Miocardiopatía no compactada. Diagnóstico. 
- Ratio NC/C ≥ 2 en telesístole (eje corto).
- Capa epicárdica fina compactada y capa endocárdica no
compactada con trabéculas y recesos profundos.
- Paso de flujo por Doppler color entre las trabéculas.
- Localización predominante: apical, lateral e inferior.
- Ausencia de otras alteraciones cardíacas. Jenni. Heart 2001. 
ECOCARDIOGRAFÍA
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low prevalence of the other primary cardiomyopathies in the 
general population, it is unlikely that all such individuals suf-
fer from LVNC. Indeed, the most probable explanation for the 
increased trabeculations and recesses observed in these states 
is a physiologically determined epiphenomenon in response to 
a chronic increase in cardiac preload.
Pregnancy is associated with doubling of maternal cardiac 
preload for at least 4 months.10 Based on the cardiovascular 
changes observed in pregnancy, a longitudinal pregnancy 
model was applied to evaluate whether increased LV trabecu-
lations observed in the aforementioned situations are a cardiac 
response to increased preload rather than LVNC. We hypoth-
esized that women with a morphologically normal LV myo-
cardium may develop LV trabeculations during pregnancy and 
that such changes would resolve within a few weeks of deliv-
ery, after normalization of blood volume.
Methods
Subjects
We conducted a prospective longitudinal echocardiographic study 
of 102 primigravida pregnant women (66 white, 36 black) between 
2010 and 2013. The women were recruited from 2 specialized ante-
natal units in south London (University Hospital Lewisham and 
St. George’s Hospital NHS Trust). All women provided consent 
and were evaluated by a self-reported health questionnaire, which 
required information relating to the presence of cardiac symptoms, 
drug history, previous miscarriages, and family history of premature 
cardiovascular disease or sudden cardiac death; physical examina-
tion; urine dipstick; 12-lead ECG; and 2-dimensional echocardiogra-
phy. The women’s ethnicity was self-assigned. All women underwent 
repeat 12-lead ECG and 2-dimensional echocardiography between 28 
to 36 weeks of gestation and 3 to 12 months postpartum.
Selection criteria for the study included age from 18 to 35 years, 
primigravida status, singleton pregnancy, black or white ethnicity, 
absence of cardiac symptoms, a structurally normal heart on echo-
cardiography without any evidence of increased LV trabeculations, 
and the ability to perform a full range of high-quality images with 
clear definition of the endocardium in the standard planes in the third 
trimester of pregnancy.
12-Lead ECG
A standard 12-lead ECG was performed with a Philips Pagewriter 
Trim III (Bothel, WA) and analyzed as previously described.11,12
Echocardiography
Two-dimensional echocardiography was performed by a cardiologist 
with accreditation in echocardiography (S.G.) with either the Philips 
Sonos 7500 or Philips iE33. Standard cardiac views were obtained 
and analyzed according to protocols specified by the American 
Society of Echocardiography.13 All measurements were recorded as 
absolute values. Cardiac dimensions and volumes were assessed as 
previously described.8 LV mass was calculated with the formula of 
Devereux and indexed for body surface area.14 Assessment of dia-
stolic function included pulsed-wave Doppler across the mitral valve 
and tissue Doppler velocity imaging of the septal and lateral mitral 
valve annuli in the apical 4-chamber view. Stroke volume was cal-
culated as the product of aortic Doppler flow velocity time integral 
and cross-sectional area of the LV outflow tract.15 Cardiac output 
was calculated as the product of stroke volume and heart rate derived 
from ECG monitoring.15 Mean arterial blood pressure was calculated 
as diastolic blood pressure minus systolic blood pressure divided by 
diastolic blood pressure. Total vascular resistance was calculated (in 
dynes·s·cm−5) with the standard formula: Total vascular resistance 
Figure 1. Graphic representation of increased left ventricular (LV) trabeculations and intertrabecular recesses on short-axis 
echocardiographic views and interpretation criteria of the Chin et al2 and Jenni et al3 for LV noncompaction (LVNC). X indicates distance 
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Introducción: Miocardiopatía no compactada: Diagnóstico.
- Herramienta muy útil para caracterización fenotípica (mayor
resolución espacial que ecocardiografía y posibilidad de
caracterización miocárdica –RTG).
- Criterios RMC: Petersen, Grothoff, Stacey, Jacquier.
- Criterio Petersen:
Zemrak. JACC 2014 (MESA study).      Weir-McCall. JACC 2016 (TASCFORCE study).    Petersen. JACC 2005. 
- NC/C ratio ≥ 2,3 en telediástole en eje largo.
- ↑ sensibilidad y ↓ especificidad.
- El más empleado en la práctica clínica.
- Utilizando Petersen, hasta el 15% de
individuos asintomáticos (sin historia CV) del
estudio TASCFORCE y 25% del MESA
cumplían criterios de MNC.
RESONANCIA MAGNÉTICA CARDÍACA
Introducción: Miocardiopatía no compactada: Diagnóstico.
Oechslin. JACC 2018. 
dysfunction was a risk factor for MACE in carriers of
mutations but not in sporadic cases (9).
LVNC: PHYSIOLOGIC OR PATHOLOGIC
REMODELING OF THE MYOCARDIUM?
Noncompaction is the description of a myocardial
phenotype with a severely thickened myocardium
presenting with a prominent noncompacted layer
(excessive trabeculations, deep intertrabecular re-
cesses), which is at least twice as thick as the com-
pacted layer. Different diagnostic criteria are used to
diagnose LVNC; although the Jenni criteria are most
frequently applied to diagnose LVNC, each of them
has its own limitations and pitfalls (15–18).
Recently, clinicians and researchers have debated
whether LVNC is a physiologic or a pathologic
phenotype of the myocardium. Genetic mutation(s)
and nongenetic factors such as loading conditions
(volume/pressure load) drive ventricular remodeling
(concentric remodeling, concentric/eccentric hyper-
trophy) and the myocardial phenotype of dilated
cardiomyopathy, hypertrophic cardiomyopathy, or
LVNC (18–24). Obviously, there seems to be a physi-
ologic, reversible remodeling of the LV myocardium
with prominent trabeculations in athletes or pregnant
women as opposed to a pathologic ventricular
remodeling in patients with a cardiomyopathy of any
cause or pathologic remodeling of the myocardium
due to pathological loading conditions (Figure 1) (8).
The identification of significantly more frequent
genetic mutations in children than in adults, associ-
ated with LV systolic dysfunction as a risk factor for
MACE, enhances our understanding of LVNC (9). The
association between a genetic mutation and LV
dysfunction as a risk factor for outcome, with LVNC
as the myocardial phenotype, strengthens the hy-
pothesis that LVNC is a genetically determined car-
diomyopathy. The results of this study emphasize the
importance of routine genetic testing to establish a
genotype–phenotype correlation and to move to the
next step, from the description of the myocardial
phenotype and morphological diagnosis to a geneti-
cally confirmed diagnosis. LVNC can occur in isola-
tion or in association with other pathologies of the
heart (e.g., congenital heart defects), with or without
associated gene mutation(s).
We are concerned that a healthy subject not be
labeled as a patient with LVNC, with a life-long
impact on this individual and on the health care
system, with unjustified regular follow-up visits and
tests. This is a call for precaution not to over-diagnose
LVNC and to establish the diagnosis of LVNC after a
careful comprehensive assessment including genetic
testing and concordant morphologic findings on the
echocardiogram and advanced cardiac imaging (e.g.,
cardiac magnetic resonance).
As volume or pressure load results in hypertrophy
of the myocardium, it can also result in the morpho-
logical appearance of LVNC, which is different from











       • Collapse, syncope, arrhythmias, heart failure
Electrocardiogram
Cardiac imaging
       • Non-compacted layer >> compacted layer; thin compacted layer





From the myocardial phenotype of LVNC to noncompaction cardiomyopathy, pathologic or physiologic reversible remodeling. LVNC ¼ left
ventricular noncompaction.
Oechslin and Jenni J A C C V O L . 7 1 , N O . 7 , 2 0 1 8
LV Noncompaction: Remodeling to Cardiomyopathy F E B R U A R Y 2 0 , 2 0 1 8 : 7 2 3 – 6
724 - Algunos autores defienden que la presencia de no compactación
es un epifenómeno de distintas condiciones fisiológicas o
patológicas.
- En un estudio muy reciente (UK Biobank) se ha encontrado
una ausencia de asociación entre los extremos de ejercicio
físico y el fenotipo de no compactación (con criterio de
Petersen).
Introducción: No compactación y ejercicio físico.
Woodbridge. Heart 2019. 
- El entrenamiento de alta intensidad se ha asociado con una
mayor prevalencia de criterios de MNC utilizando
ecocardiografía y RMC.
- Sin embargo, se desconoce si esta asociación también aplica
a la población general.
- Objetivo: Evaluar la asociación entre actividad física y fenotipo
de no compactación en población general (cohorte PESA).
Discusión
• Se ha identificado un patrón ecocardiográfico de no
compactación en algunas situaciones de estrés (fisiológico).
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was determined with the use of the 16-segment model recommended 
by the American Society of Echocardiography.13
Ethical Approval/Consent
The National Research Ethics Service, East London 2 Research 
Ethics Committee granted ethical approval in the UK.
Statistical Analysis
Statistical analyses were performed with SPSS version 18.0 (SPSS, 
Inc, Chicago IL). Variables were tested for normality with the 
Kolmogorov-Smirnov test. Values are expressed as either mean±SD 
or percentages as appropriate. Differences within group means were 
compared by use of the paired Student t test or the Wilcoxon test, 
and differences between group means were compared by use of inde-
pendent t tests or Mann-Whitney U tests (for normally and nonnor-
mally distributed variables, respectively). The χ2 test or Fisher exact 
test was used as appropriate to test group differences of proportions. 
Repeated-measures ANOVA was performed to evaluate changes in 
the clinical and echocardiographic parameters during pregnancy and 
the postpartum period. Logistic regression was used to determine 
multiple-adjusted risk for the presence of increased (≥3) trabecula-
tions during pregnancy in relation to ethnicity, age, body mass index, 
heart rate, blood pressure, LV stroke volume, LV cavity and volume 
size, and LV mass. Statistical significance was defined as a 2-tailed 
value of P<0.05 throughout.
Reproducibility of LV and RV measurements was assessed with 
intraclass correlation coefficient analysis and reported as intraclass 
correlation coefficient (95% confidence interval). Averaged mea-
sures were used as an index for the reliability of 2 different rates. 
Intraobserver and interobserver agreement for the presence of LV tra-
beculations was assessed by κ statistics.
Results
Subjects
Pregnant women had a mean age of 30.7±4.4 years and a body 
surface area of 1.8±0.3 m2. The majority (64.7%) were white. 
None of the women had a family history of cardiomyopathy 
or premature (<40 years of age) sudden cardiac death. All 
women were normotensive (blood pressure ≤120/80 mm Hg), 
and none revealed proteinuria.
Hemodynamic and Structural Changes  
During Pregnancy
The progression of pregnancy from the first trimester to the 
third trimester was accompanied by increases in heart rate, 
stroke volume, and cardiac output and a reduction in total 
vascular resistance. Advancing pregnancy was also associ-
ated with a modest (11%–12%) increase in LV volume and 
LV mass (Table 1).
Pregnant Women With Increased LV Trabeculations
Twenty-five percent of pregnant women developed increased 
LV trabeculations (Figure 2), which were more common in 
black women than in white women (47.2% versus 13.6%; 
P=0.0003). Of the total pregnancy cohort, 10 women (9.8%) 
fulfilled the Jenni et al criteria, 19 (18.6%) fulfilled the Chin 
et al criteria, and 8 (7.8%) fulfilled both criteria for LVNC 
(Figure 3). Women fulfilling both criteria did not show any 
significant ethnic predilection (black: n=4, 11.1%; white: 
n=4, 6.1%; P=0.459). During pregnancy, the Chin et al X/Y 
ratio at the site of maximal wall thickness averaged 0.43±0.07 
(range, 0.35–0.5), and the Jenni et al ratio of noncompacted to 
compacted myocardial at the site of maximal wall thickness 
averaged 2.2±0.6 (range, 2.1–3.4).
LV trabeculations were distributed predominantly in the 
anterolateral territory (n=14), followed by the inferolateral 
(n=7), inferior (n=7), apical lateral (n=7), and apical inferior 
(n=6) regions.
Differences in ECG and Echocardiographic 
Parameters in Pregnant Women Exhibiting 
Increased LV Trabeculations and Those With 
Normal Cardiac Morphology
Pregnant women who developed LV trabeculations did not 
differ from those without LV trabeculations in terms of elec-
trocardiographic abnormalities. One pregnant woman with LV 
trabeculations showed minor T-wave inversion in leads V1 and 
V2 on the baseline ECG, as did 1 woman with normal myo-
cardial morphology, which persisted during pregnancy and for 
12 months postpartum. There were no significant differences 
in wall thickness, cavity size, indexes of systolic and diastolic 
function, or stroke volume between the women in the 2 groups 
(Table 2). None of the women in the study exhibited abnormal 
systolic or diastolic function.
Figure 2. A 2-dimensional echocardiographic example 
of a woman who developed de novo left ventricular (LV) 
trabeculations during the progression of pregnancy, which 
regressed in the postpartum period.
Figure 3. A 2-dimensional echocardiographic example of 1 of 
8 women who fulfilled both the Chin et al2 criteria and Jenni 
et al3 criteria for noncompaction during the third trimester of 
pregnancy. C indicates compacted layer; NC, noncompacted 
layer; X, distance from the epicardial surface to the trough of 
the intertrabecular recess; and Y, distance from the epicardial 








Left ventricular (LV) noncompaction (LVNC) cardiomyopa-thy is an unclassified primary cardiomyopathy character-
ized by increased myocardial trabeculations and recesses. The 
precise stage of development and the natural history of the con-
dition are not fully understood; however, preliminary data are 
indicative of a morphologically and clinically heterogeneous 
disorder. Some individuals present with overt heart failure, fatal 
arrhythmias, and thromboembolic events, and others remain 
asymptomatic.1 Echocardiographic criteria to facilitate the iden-
tification and assessment of LVNC rely on the presence of LV 
myocardial trabeculations and a 2-layer distinction between 
compacted and noncompacted myocardium (Figure 1).2–5
Editorial see p 453 
Clinic l Perspective on p 483
The past 2 decades have wit essed significant advances in 
tissue harmonics, which have enabled detailed assessment of 
the ventricular myocardium. Such progress in image resolu-
tion has coincided with an increasing number of scientific 
reports relating to LVNC. The initial prevalence of LVNC was 
estimated to be <0.3%.2,6 However, recent studies in patients 
with heart failure have reported a high proportion (almost 
35%) of patients with myocardial trabeculations, with nearly 
25% fulfilling diagnostic criteria for LVNC regardless of the 
criteria used.7 A study of >1000 athletes demonstrated that 
18% exhibited increased LV trabeculations and 8% fulfilled 
echocardiographic criteria for LVNC.8 Patients with sickle cell 
anemia also reveal a high (28.3%) prevalence of increased LV 
trabeculations.9 A common theme among all 3 cohorts is the 
presence of an increased cardiac preload. Given the relatively 
Background—Patients with heart failure and chronic anemia frequently demonstrate left ventricular (LV) trabeculations, 
which may be compatible with the diagnosis of LV noncompaction. We used the pregnancy model, which is characterized 
by a reversible increase in cardiac preload and other changes in cardiac function, to assess the development of de novo 
LV trabeculations in women with morphologically normal hearts.
Methods and Results—One hundred two primigravida pregnant women were evaluated longitudinally with a series of 
echocardiograms in the first trimester, in the third trimester, and postpartum. Echocardiograms were analyzed according 
to established guidelines. Increased LV trabeculations and the presence of LV noncompaction were based on established 
criteria. Pregnancy was associated with an increased heart rate, stroke volume, and cardiac output, as well as increased 
LV volume and mass. During pregnancy, 26 women (25.4%) developed increased trabeculations. Eight women showed 
sufficient trabeculations to fulfill criteria for LV noncompaction. During the postpartum follow-up period of 24±3 
months, 19 women (73%) demonstrated complete resolution of trabeculations, and 5 showed a marked reduction in the 
trabeculated layer.
Conclusions—Pregnancy induces de novo LV trabeculations in a significant proportion of women. The results suggest that 
LV trabeculations occur in response to increased LV loading conditions or other physiological responses to pregnancy 
and are not specific for LV noncompaction. These factors should be considered in the assessment of individuals 
with LV trabeculations outside the context of symptoms of heart failure or familial cardiomyopathy.  (Circulation. 
2014;130:475-483.)
Key ords: cardiomyopathi s ◼ echocardiography ◼ ethnic groups ◼ isolated noncompaction of the  
ventricular myocardium ◼ pregnancy
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- 102 embarazadas v luadas
longitudinalm te on cocardiografía.
- Una cuarta p rte de ellas (25,4%)
desarrollaron hipertrabeculación
dur te el mbarazo, que se resolvió en
el postparto.
Discusión
• “Un ventrículo trabeculado vs. no trabeculado puede trabajar
con menor strain para generar el mismo volumen latido.
Bruno. Int J for numerical methods in biomedical engineering 2018.
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Relationship between the left ventricular size and the amount of trabeculations 
Bruno Paun, Bart Bijnens, Constantine Butakoff* 
 
Using a geometrical model of the left ventricle we show that: a trabeculated ventricle can 
work at lower strains compared to a nontrabeculated one to produce the same stroke volume; 
the trabeculations can help increasing stroke volume with less strain; it is possible to find an 
optimal amount of trabeculations, where SV is optimized while LV size remains within 
physiological ranges; the trabeculations are necessary for a more efficient cardiac function, 











extra sin aumentar el
estrés del VI.
Conclusión
• Los criterios actuales de imagen (RMC) son excesivamente
sensibles para detección de MNC.



















































.supportive features include LV systolic dysfunction, with reduced
(<50%) ejection fraction, but also a very thin compacted epicardial
layer (i.e. <8 mm in systole on echocardiography)64 and abnormal
myocardial relaxation (e0 <9 cm/s at TDI.65
Athletes frequently show increased trabeculations in the LV cavity
(i.e. so-called hypertrabeculation pattern), and up to 8% may fulfil the
morphological criteria for LVNC.65 It has been postulated that an
increased cardiac preload may simply unmask pre-existing trabecula-
tions and make them more prominent. This hypothesis is supported
by a longitudinal study, using the pregnancy model, which showed
that almost 25% of primigravida women developed prominent trabe-
culation and 8% fulfilled criteria consistent with LVNC as pregnancy
progressed to the third trimester.66
Only a small proportion (0.9%) of athletes with hypertrabecula-
tion exhibit other clinical abnormalities supportive for diagnosis
of a cardiomyopathy; these athletes need to be thoroughly inves-
tigated.65 Specifically, athletes with LV hypertrabeculation and an
abnormal ECG and/or mildly reduced LV function, or positive
family history should undergo a complete evaluation including
CMR and exercise echocardiography to assess the LV response to
effort, and ECG Holter monitoring to ascertain the presence of
arrhythmias, all findings that will support the diagnosis of
LVNC.6,65,66–70
Risk stratification
The clinical outcome of LVNC is variable, even within families, and
governed by the magnitude of LV dysfunction and prevalence of atrial
and ventricular arrhythmias or thromboembolic events. Adverse
consequences are largely associated with LV systolic dysfunction or
major ventricular tachyarrhythmias. It is noteworthy that no major
cardiac events have been reported in the absence of LV dysfunction,
regardless the severity of hypertrabeculation.65,67–70
Recommendations
As specified above, advising an individual with LVNC regarding par-
ticipation to competitive sport requires a comprehensive and clear
explanation, and assurance of understanding of the associated risks
on behalf of the candidate (Table 5).
Arrhythmogenic (right
ventricular) cardiomyopathy
Arrhythmogenic right ventricular cardiomyopathy (ARVC), or simply
arrhythmogenic cardiomyopathy (AC) is an inherited myocardial dis-
ease caused predominantly by mutations in genes encoding desmo-
somal proteins. The disease is characterized histologically by fibro-
fatty replacement of the right ventricle and/or LV myocardium, and
clinically by life-threatening ventricular tachyarrhythmias.71 Sudden
death usually occurs in young AC individuals and is often triggered by
exercise. Arrhythmogenic cardiomyopathy represents a common
cause of SCD in prospective studies of young athletes in Italy72 and in
an unselected population of young adults from Australia.73
The diagnosis of AC is based on the criteria proposed by an expert
consensus panel that recognize electrophysiological, anatomical, and
clinical features of the disease.74
12-lead ECG
The ECG is of particular value in raising suspicion for AC and is abnor-
mal in the majority (>60%) of individuals.75 The most common abnor-
malities in the right-dominant variant include inverted T-waves in the
right precordial leads (V1–V3), prolonged QRS duration >110 ms with
right bundle branch block (RBBB) pattern and a delayed upstroke (>55
ms) of the S wave in V1–V2. Rare is the presence of an epsilon wave in
V1 or V2. In the left-dominant variant low voltages of R/S wave in the
limb leads are increasingly recognized, as well as the presence of diffuse
....................................................................................................................................................................................................................
Table 5 Recommendations for athletes with LVNC
Class/level of evidence
1. Athletes with incidental discovery of LV hypertrabeculation should not be diagnosed as LVNC in the absence of
symptoms, positive family history, abnormal ECG patterns and, most importantly, impaired LV function. In such cases,
no restriction for all competitive sports apply.
Class IIa/Level B
2. Athletes with unequivocal/reasonable diagnosis of LVNC but near-normal LV systolic function may participate in all
competitive sports, with the exception of those where occurrence of syncope may cause serious harm or death
(Figure 1), if they are:
(1) asymptomatic,
(2) without frequent and/or complex ventricular arrhythmias, or non-sustained VT on ambulatory monitoring and
exercise ECG testing, and
(3) no prior history of unexplained syncope
Class IIb/ Level C
3. Athletes with an unequivocal diagnosis of LVNC and
(1) impaired LV systolic function and/or
(2) frequent and/or complex ventricular arrhythmias, or non-sustained VT on ambulatory monitoring or exercise
testing should be advised to abstain from participation in competitive sports.
Class III/ Level C
These patients should be advised to limit their exercise programmes to leisure-time physical activities and remain under
regular clinical surveillance.



















































































































• Propuesta para diagnóstico definitivo de MNC:
1. Cumplir algún criterio diagnóstico de imagen en eje corto
(Jenni/Jacquier/Grothoff/Stacey).
2. Presentar alguna de las siguientes características:
- MNC diagnosticada en otro miembro de la familia.
- Alteraciones asociadas a la hipertrabeculación en el estudio de
imagen (por ejemplo WMA).
- Complicaciones asociadas a MNC (IC, arritmias,
tromboembolismo).
- Portadores de mutaciones patogénicas.
Garcia-Pavia P, de la Pompa JL. JACC 2014.
¡Gracias!
Relación entre la hipertrabeculación
ventricular izquierda y el ejercicio. 
